Epidemiological aspects of COVID-19 in pregnant women in the state of Amazonas, Brazil
European Gynecology & Obstetrics · 22.05.2023 · 4 (2)
DOI: 10.53260/ego.22402038 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Gynecology & Obstetrics, online erschienen am 22.05.2023. Verfasst von Ana Paula Coelho Marques und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and purpose: Pregnant women if infected with COVID-19 are vulnerable and considered as a risk group. The objective of this research was to analyze the epidemiological aspects of COVID-19 cases in pregnant women registered from 2020 to 2021, in the State of Amazonas, Brazil.
Methods
This was an analysis of data obtained from the website of the Brazilian Obstetric Observatory COVID-19 (OOBr COVID-19).
Results
During the defined study period a total of 565 pregnants were diagnosed with severe acute respiratory syndrome caused (SARS) by COVID-19 in the Amazon state. Of these 546 (96.6%) required hospitalization, 9 (1.6%) were not hospitalized and 10 (1.8%) did not report if they need hospitalization or not. The highest number of cases was recorded in the third trimester of pregnancy (n=291, 51.5%), followed by the second trimester (n=130, 23.0%), unreported gestational age (n=76, 13.5%) and by the first gestational trimester (n=68, 12.0%). A 64.2% of affected women were predominantly young adults, aged 20 to 34 (n=363). Regarding antiviral treatment, 50.1% (n=283) used Zanamivir and 24.2% (n=137) used Oseltamivir. A 25.7% (n=145) did not report the used medication. The most reported symptoms were cough, fever, dyspnea, respiratory distress, odynophagia, low oxygen saturation, fatigue, diarrhea, vomiting, anosmia/hyposmia, ageusia and abdominal pain. The most frequently associated conditions were asthma, diabetes, cardiovascular disease, obesity, hematological disease, neuropathies, immunodepression, liver disease, pneumopathies and kidney disease. A 12.4% of the women (n=70) required ICU and 64.4% (n=364) did not. A 19.1% (n=108) required noninvasive ventilatory support (NIV), 8.8% (n=50) invasive ventilation (IV) and 42.5% (n=240) no ventilatory support. A 79.5% (n=449) of the pregnant women with COVID-19 were cured and an 8.0% (n=45) died.
Conclusions
Due to complications, and scarcity of information during pregnancy, systematized care and COVID-19 vaccination in this risk group is needed.
Zitieren
APA
Marques, A. P. C., Rangel, F. K. D. S., & Queiroz, S. M. L. D. (2023). Epidemiological aspects of COVID-19 in pregnant women in the state of Amazonas, Brazil. European Gynecology & Obstetrics, 4(2). https://doi.org/10.53260/ego.22402038
Vancouver
Marques APC, Rangel FKDS, Queiroz SMLD. Epidemiological aspects of COVID-19 in pregnant women in the state of Amazonas, Brazil. European Gynecology & Obstetrics. 2023;4(2). doi:10.53260/ego.22402038
BibTeX
@article{Marques2023,
author = {Marques, Ana Paula Coelho and Rangel, Flávia Krichanã Dos Santos and Queiroz, Sigrid Maria Loureiro de},
title = {Epidemiological aspects of COVID-19 in pregnant women in the state of Amazonas, Brazil},
journal = {European Gynecology & Obstetrics},
year = {2023},
volume = {4},
number = {2},
doi = {10.53260/ego.22402038}
}
EUVIMED